Sentences with phrase «cancer outcomes research»

Angela K. Green, MD, MSc, formerly of the UNC Lineberger's Cancer Outcomes Research Program and the UNC School of Medicine who is now at the Memorial Sloan Kettering Cancer Center, was also a co-author of the viewpoint.

Tags: bankruptcy, D. Gary Gilliland, hutchinson institute for cancer outcomes research, Study of Cancer Diagnosis as a Risk Factor for Personal Bankruptcy, value cancer care summit

Financial toxicity is a major concern and frequent topic of study by the Hutchinson Institute for Cancer Outcomes Research at Fred Hutch.

Not exact matches

Future resources from the NCI Center for Cancer Genomics (CCG), which oversees TCGA and other activities, will support more translationally focused research, including databases with genomic information on clinical samples linked to outcomes of their patient donors.

If hypofractionated radiation with curative intent can reduce the treatment time for lung cancer patients by half with no greater toxicity, and with equivalent — if not better — tumor control and survival outcomes, this research could result in a change in the paradigm of how a large subset of locally advanced NSCLC patients are treated.»

The research identifies a potential characteristic for predicting outcome in a deadly form of brain cancer known as glioblastoma multiforme.

«It was a predictable outcome for those of us who believe in the technology already» says Mark Schiffman, who leads research into HPV at the National Cancer Institute in Washington DC.

Recently research published in Cancer Discovery showed that changing the schedules of drug administration can improve outcomes leading to more complete responses in mouse models of the disease.

Outcomes depended upon disease severity before treatment, oncologist Jae Park reported April 3 at the American Association for Cancer Research annual meeting.

Called the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) and funded by the drug giant Novartis, the trial also found fewer cases of lung cancer in those on the treatment, rekindling basic research findings hinting that the same inflammatory pathway may initiate or spur the growth of such tumors.

«While the presence of lymphocytes in tumors is often associated with better clinical outcomes, this research adds clarity on the diversity of T cells within the tumor environment and their influence on ovarian cancer outcomes,» says first author Kunle Odunsi, MD, PhD, FRCOG, FACOG, Deputy Director, M. Steven Piver Professor and Chair of Gynecologic Oncology, and Executive Director of the Center for Immunotherapy at Roswell Park.

Besides working at IBM's Thomas J. Watson Research Center in Yorktown Heights, New York, Meyer heads something called the DREAM challenges, contests that ask teams of computer scientists to solve outstanding biomedical problems, such as predicting the outcome of prostate cancer treatment based on clinical variables or detecting breast cancer from mammogram data.

An oral cancer drug improves outcomes while minimizing side effects in women with gynecologic cancers who carry a BRCA mutation and whose disease is not responding to other therapies, suggests preliminary research.

And Mark Clanton, deputy director for cancer care and delivery, started «important» new outcomes research programs, Fox Chase's Young notes.

Among postmenopausal women with normal body mass index (BMI), those with higher body fat levels had an increased risk for invasive breast cancer, according to data presented at the American Association for Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27cancer, according to data presented at the American Association for Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27Cancer Research Special Conference Obesity and Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27Cancer: Mechanisms Underlying Etiology and Outcomes, held Jan. 27 - 30.

The application of NGS to breast cancer research has enabled the development of cost - effective, multigene sequencing panels that have advanced our understanding of the disease and may in the future translate into better diagnosis and outcomes for patients.

Severe health effects have been observed in populations drinking arsenic - contaminated water over long periods, and research has established that drinking water contaminated with arsenic causes skin cancer and several internal cancers such as lung, bladder, and kidney cancer, as well as cardiovascular disease and other adverse outcomes.

Earlier research among patients with colon cancer has revealed worse outcomes among those with lifestyle factors that heighten insulin resistance, such as obesity, lack of exercise, and a diet with high levels of carbohydrates that quickly raise levels of blood sugar.

Detailed evaluation of a prostate cancer tumor biopsy may predict treatment outcomes for image - guided radiation therapy (IGRT) or surgery for prostate cancer, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

Detailed evaluation of a prostate cancer tumor biopsy may predict treatment outcomes for image - guided radiation therapy (IGRT) or surgery for prostate cancer, according to research presented at the American Society for Radiation Oncology's (ASTRO's) 55th Annual Meeting.

The research, led by Daniel Krauss, M.D., a radiation oncologist, Beaumont Hospital — Royal Oak, found an association between positive post-radiation therapy biopsy results and subsequent clinical outcomes in men with localized prostate cancer.

Colin Collins and Alexander Wyatt, and other researchers from the Vancouver Prostate Centre at the Vancouver Coastal Health Research Institute, matched 25 patients» treatment outcomes with the RNA sequence of their prostate cancer tumors.

Only a third of older breast cancer patients saw a cardiologist within 90 days of developing heart problems, in a study presented at the American Heart Association's Quality of Care and Outcomes Research 2014 Scientific Sessions.

«Based on this research, we are now conducting a first - in - human study combining the PARP inhibitor with radiation and chemotherapy in patients with locally advanced pancreatic cancer, with an ultimate goal of improving survival rates and treatment outcomes,» said Tuli.

Research coordinated by the ECOG - ACRIN Cancer Research Group, supported in part by the National Cancer Institute, and published in the current online version of The New England Journal of Medicine, examined the outcomes of giving the chemotherapy drug docetaxel at the start of ADT.

Research has suggested that standard therapies combined with drugs that inhibit PARP1 can kill cancer cells, but clinical trials testing PARP1 inhibitors in cancer patients have produced disappointing outcomes.

«To move the needle forward toward prolonged survival and better treatment outcomes, our research team created a combined investigational regimen for patients with locally advanced pancreatic cancer,» said Richard Tuli, MD, PhD, a radiation oncologist in the Department of Radiation Oncology and a member of the Samuel Oschin Comprehensive Cancer Instcancer,» said Richard Tuli, MD, PhD, a radiation oncologist in the Department of Radiation Oncology and a member of the Samuel Oschin Comprehensive Cancer InstCancer Institute.

«We are very excited with the outcome of this work,» said lead author Simone Treiger Sredni, MD, PhD, Associate Professor of Pediatric Neurosurgery at Northwestern University Feinberg School of Medicine and cancer researcher at the Stanley Manne Children's Research Institute of Ann & Robert H. Lurie Children's Hospital of Chicago.

In 2009, the UK Medical Research Council and National Institute of Health Research, through the Efficacy and Mechanism Evaluation Programme, funded the Robotic vs Laparoscopic Resection for Rectal Cancer (ROLARR) trial to undertake an evaluation of the safety, efficacy, and short - and long - term outcomes of robotic - assisted vs conventional laparoscopic rectal cancer suCancer (ROLARR) trial to undertake an evaluation of the safety, efficacy, and short - and long - term outcomes of robotic - assisted vs conventional laparoscopic rectal cancer sucancer surgery.

A type of kidney tumor can progress along one of three distinct evolutionary pathways, each with different clinical outcomes, according to research presented Sunday (April 15) at the American Association for Cancer Research (AACR) meeting in research presented Sunday (April 15) at the American Association for Cancer Research (AACR) meeting in Research (AACR) meeting in Chicago.

Share knowledge and drive the debate on outcomes research, health economics and organisation of cancer care delivery

The mission of the Department of Population Sciences is to advance the science and application of cancer etiology, prevention and outcomes, and reduce the burden of cancer and its sequelae across all populations, through collaborative multidisciplinary programs in clinical service, research and education.

Cancer Research Institute iAtlas Poised to Improve Patient Outcomes by Providing Researchers Greater Access to Genomics Data

Building on the successful outcomes of their multi-year history, these leading cancer research organizations will inspire new collaborators; improve diagnosis of pancreatic cancer using big data; develop new treatments for pancreatic cancer; and support the next generation of pancreatic cancer investigators.

Drawing together all three pillars of the Summit (Outcomes Research, Health Economics of Cancer Care, Organisation of Cancer Care Delivery), this concluding session will reflect on key survivor issues, including as well legal and regulatory matters, such as:

It's divisions include Cancer Etiology, Center for Cancer Survivorship, CCARE, Clinical Cancer Genetics, Nursing Research and Education, Outcomes Research, and BMT Study.

The study was funded in part by the Patient - Centered Outcomes Research Institute, the Agency for Healthcare Research and Quality; the Integrated Cancer Information and Surveillance System; UNC Lineberger; and the University Cancer Research Fund.

She also conducts clinical research evaluating prognosticators of outcome in patients with liver, bile duct and liver tumors and investigates new imaging agents in pancreas and liver cancers.

The MD Anderson Cancer Center Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy is home to an integrated clinical cancer research and clinical trials program that is aimed at implementing personalized cancer therapy and improving patient outCancer Center Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy is home to an integrated clinical cancer research and clinical trials program that is aimed at implementing personalized cancer therapy and improving patient outCancer Therapy is home to an integrated clinical cancer research and clinical trials program that is aimed at implementing personalized cancer therapy and improving patient outcancer research and clinical trials program that is aimed at implementing personalized cancer therapy and improving patient outcancer therapy and improving patient outcomes.

The Biden Cancer Initiative is dedicated to developing and driving the implementation of solutions to accelerate progress in cancer prevention, detection, diagnosis, research, and care, and to reducing disparities in cancer outCancer Initiative is dedicated to developing and driving the implementation of solutions to accelerate progress in cancer prevention, detection, diagnosis, research, and care, and to reducing disparities in cancer outcancer prevention, detection, diagnosis, research, and care, and to reducing disparities in cancer outcancer outcomes.

His most recently awarded grants are from the Agency for Health Care Research and Quality, where he is Co-PI of the program project grant, «Eliminating Racial Disparities in Health,» and from the Centers for Disease Control where he is PI of a constituent case - case project comparing prostate cancer outcomes among African Americans and Caucasians.

As a translational cancer researcher I have the opportunity to provide frontline research which can directly influence cancer patient survival outcomes.

The current phase of her research program, conducted in the division of Cancer Care and Epidemiology (CCE) at the Queen's Cancer Research Institute, involves extracting information from pathology reports in patients with biliary tract cancer and looking at the natural history, treatment outcomes, and mortality trends in this popresearch program, conducted in the division of Cancer Care and Epidemiology (CCE) at the Queen's Cancer Research Institute, involves extracting information from pathology reports in patients with biliary tract cancer and looking at the natural history, treatment outcomes, and mortality trends in this populCancer Care and Epidemiology (CCE) at the Queen's Cancer Research Institute, involves extracting information from pathology reports in patients with biliary tract cancer and looking at the natural history, treatment outcomes, and mortality trends in this populCancer Research Institute, involves extracting information from pathology reports in patients with biliary tract cancer and looking at the natural history, treatment outcomes, and mortality trends in this popResearch Institute, involves extracting information from pathology reports in patients with biliary tract cancer and looking at the natural history, treatment outcomes, and mortality trends in this populcancer and looking at the natural history, treatment outcomes, and mortality trends in this population.

Given the very high survival rate for patients with Hodgkin lymphoma, many research studies now focus on learning how to eliminate potential late effects (e.g., secondary cancers) while maintaining excellent outcomes.

A gene linked to bowel cancer recurrence and shortened survival could help predict outcomes for patients with the gene - and take scientists a step closer to development of personalized treatments, reveals research in the journal Gut.

These research collaborations have the power to answer questions critical to improving cancer outcomes, such as how tumors develop drug resistance, and what treatments are most effective against particular genomic traits.

Tags: Cancer etiology - prevention - outcomes, Clinical Research, Eddie Mendez, Harlan Robins, head neck cancers, Herbold Computational Biology Program, Public Health Sciences

Research is critical to understanding the unique health challenges these survivors face, and Fred Hutchinson Cancer Research Center investigators lead the way in examining long - term outcomes as well as interventions that help these patients take control of their health and happiness.

Advances in cancer care and research are occurring at an extremely rapid pace, improving patient outcomes and survivorship.

Tags: aspirin, Bezos, bioengineering, Breast Cancer, Cameron Turtle, Cancer etiology - prevention - outcomes, CAR t - cell, Clinical Research, Colorectal Cancer, genome, hiv, hiv vaccine, hiv vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer, mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - Viral cCancer, Cameron Turtle, Cancer etiology - prevention - outcomes, CAR t - cell, Clinical Research, Colorectal Cancer, genome, hiv, hiv vaccine, hiv vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer, mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - Viral cCancer etiology - prevention - outcomes, CAR t - cell, Clinical Research, Colorectal Cancer, genome, hiv, hiv vaccine, hiv vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer, mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - ViralResearch, Colorectal Cancer, genome, hiv, hiv vaccine, hiv vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer, mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - Viral cCancer, genome, hiv, hiv vaccine, hiv vaccine trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer, mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - Viral ccancer, mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - Viralresearch, Vaccine and Infectious Disease, Vaccine development - Viral cancers